Encapsulated Escitalopram and Paroxetine Intranasal Co-Administration: In Vitro/In Vivo Evaluation

Depression is a common mental disorder. Its treatment with selective serotonin reuptake inhibitors (SSRIs) is effective only in a fraction of patients, and pharmacoresistance is increasing steadily. Intranasal (IN) drug delivery to the brain stands out as a promising strategy to improve current ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Soraia, Bicker, Joana, Fonseca, Carla, Ferreira, Nuno R., Vitorino, Carla, Alves, Gilberto, Falcão, Amílcar, Fortuna, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675330/
https://www.ncbi.nlm.nih.gov/pubmed/34925013
http://dx.doi.org/10.3389/fphar.2021.751321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675330/
https://www.ncbi.nlm.nih.gov/pubmed/34925013
http://dx.doi.org/10.3389/fphar.2021.751321

Ejemplares similares